IL-6, IL-12p70, and IL-17 could interact with each other and commonly participate in the development of ILD and joint symptoms by activated B lymphocytes and induced naïve CD4+ T cells in pSS-ILD patients. This evidence concerns the gene CD4 and interstitial lung disease.